Soma Jobbagy, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-E2-Related Factor 2 | 3 | 2020 | 379 | 0.870 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 167 | 0.750 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2020 | 23 | 0.720 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 25 | 0.680 |
Why?
|
| Hamartoma | 1 | 2021 | 238 | 0.670 |
Why?
|
| Lithium | 1 | 2020 | 601 | 0.570 |
Why?
|
| Glutathione | 1 | 2018 | 590 | 0.550 |
Why?
|
| Chest Pain | 1 | 2021 | 1114 | 0.460 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 1363 | 0.420 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3817 | 0.330 |
Why?
|
| Heart Diseases | 1 | 2021 | 2789 | 0.310 |
Why?
|
| Nasal Cavity | 1 | 2022 | 313 | 0.180 |
Why?
|
| Cyclooxygenase 1 | 1 | 2020 | 104 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2132 | 0.170 |
Why?
|
| Glutathione Disulfide | 1 | 2018 | 29 | 0.170 |
Why?
|
| Alkylation | 1 | 2018 | 86 | 0.170 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2020 | 329 | 0.170 |
Why?
|
| Aquaporin 2 | 1 | 2020 | 148 | 0.160 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 107 | 0.160 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2018 | 14 | 0.160 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2017 | 18 | 0.150 |
Why?
|
| Intracellular Space | 1 | 2018 | 212 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 298 | 0.150 |
Why?
|
| Catalysis | 1 | 2018 | 762 | 0.150 |
Why?
|
| Catalytic Domain | 1 | 2018 | 698 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 2184 | 0.140 |
Why?
|
| Cyclic GMP | 1 | 2017 | 409 | 0.140 |
Why?
|
| Biomimetics | 1 | 2016 | 172 | 0.130 |
Why?
|
| Acyltransferases | 1 | 2016 | 294 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2076 | 0.100 |
Why?
|
| Kinetics | 1 | 2018 | 6476 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
| Immunoconjugates | 1 | 2018 | 901 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 1058 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2021 | 4576 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14561 | 0.080 |
Why?
|
| Androgen Antagonists | 1 | 2016 | 1377 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3084 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13814 | 0.070 |
Why?
|
| Mice | 5 | 2020 | 81201 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2018 | 3589 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2200 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12961 | 0.070 |
Why?
|
| Melanoma | 1 | 2023 | 5511 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21833 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7184 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5692 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7882 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5027 | 0.050 |
Why?
|
| Animals | 5 | 2020 | 168768 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 13882 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 744366 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10637 | 0.040 |
Why?
|
| Proteinuria | 1 | 2020 | 658 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 23404 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1020 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1692 | 0.030 |
Why?
|
| Benzoates | 1 | 2017 | 217 | 0.030 |
Why?
|
| Female | 3 | 2022 | 380193 | 0.030 |
Why?
|
| Child | 1 | 2022 | 77709 | 0.030 |
Why?
|
| Myocarditis | 1 | 2021 | 771 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
| Vasodilation | 1 | 2017 | 944 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 1504 | 0.020 |
Why?
|
| Aorta | 1 | 2017 | 2062 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2499 | 0.020 |
Why?
|
| Echocardiography | 1 | 2021 | 5099 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4153 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 214052 | 0.020 |
Why?
|
| Myocardium | 1 | 2021 | 4772 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4208 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 213390 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13286 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4600 | 0.020 |
Why?
|
| Male | 2 | 2021 | 350115 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 9857 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29060 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19233 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 24252 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18034 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77460 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163288 | 0.010 |
Why?
|